Provided by Tiger Fintech (Singapore) Pte. Ltd.

Keros Therapeutics, Inc.

14.45
+0.19001.33%
Post-market: 14.500.0500+0.35%19:35 EDT
Volume:1.41M
Turnover:20.30M
Market Cap:586.12M
PE:-2.89
High:14.56
Open:14.02
Low:14.01
Close:14.26
Loading ...

BUZZ-Keros Therapeutics drops on halting lung disease trial on safety concerns

Reuters
·
15 Jan

Keros halts blood pressure treatment trial on safety issues

Reuters
·
15 Jan

Keros Therapeutics Shares Down 7.7% Premarket After Co Halts Mid-Stage Blood Pressure Drug Trial

THOMSON REUTERS
·
15 Jan

Keros Therapeutics Halts Pulmonary Hypertension Treatment Trials Due to Adverse Effects

Dow Jones
·
15 Jan

Keros halts hypertension treatment trial on safety issues

Reuters
·
15 Jan

Keros Therapeutics Inc - Tropos Trial Terminated Early, Patients to Be Monitored

THOMSON REUTERS
·
15 Jan

Keros Therapeutics Inc - Expects to Present Topline Data in Q2 2025

THOMSON REUTERS
·
15 Jan

Keros Therapeutics Inc - Halts All Dosing in Tropos Trial Due to Safety Review

THOMSON REUTERS
·
15 Jan

Keros Therapeutics Announces Additional Update on the Phase 2 Tropos Trial

THOMSON REUTERS
·
15 Jan

Truist Slashes Price Target on Keros Therapeutics to $43 From $100, Keeps Buy Rating

MT Newswires Live
·
23 Dec 2024

Keros Therapeutics Inc : Truist Securities Cuts Target Price to $43 From $100

THOMSON REUTERS
·
23 Dec 2024

BUZZ-Guggenheim downgrades Keros Therapeutics to 'neutral'

Reuters
·
17 Dec 2024

Keros Therapeutics Inc. : Oppenheimer Cuts Target Price to $63 From $102

THOMSON REUTERS
·
16 Dec 2024

Guggenheim Downgrades Keros Therapeutics to Neutral From Buy

MT Newswires Live
·
16 Dec 2024

Analysts’ Top Healthcare Picks: Aldeyra Therapeutics (ALDX), Keros Therapeutics (KROS)

TIPRANKS
·
16 Dec 2024

Keros Therapeutics Inc : Guggenheim Cuts to Neutral From Buy

THOMSON REUTERS
·
16 Dec 2024

Keros Therapeutics Cut to Neutral From Buy by Guggenheim

Dow Jones
·
16 Dec 2024

U.S. RESEARCH ROUNDUP-Amazon, Ford, Netflix

Reuters
·
16 Dec 2024

Keros Therapeutics Inc : Piper Sandler Cuts Target Price to $40 From $105

THOMSON REUTERS
·
16 Dec 2024

Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS), AnaptysBio (ANAB) and US Physical Therapy (USPH)

TIPRANKS
·
16 Dec 2024